Synthesis,Crystal Structure and Biological Activity of 5-(2-Methylphenyl)-1,3,4-oxadiazol-2(3H)-one Derivatives

3-Methyl-5-(2-methylphenyl)-1,3,4-oxadiazol-2(3H)-one(6) and N,N-diethyl-2-(2-methylbenzoyl)-hydrazinecarboxamide(7) were designed and synthesized from 5-(2-methylphenyl)-1,3,4-oxadiazol-2(3H)-one(5) by substituting and ring-opening, respectively. The target compounds were confirmed by IR, 1H NMR spectroscopy, MS, elemental analysis and single-crystal X-ray diffraction. Compound 6(C10H10N2O2, Mr = 190.20) crystallizes in the triclinic system, space group P 1 with a = 7.4645(16), b = 10.868(2), c = 12.970(3) A, α= 110.542(2), β= 98.142(2), γ=99.766(2)°, V = 947.7(3) A3, Z = 4, F(000) = 400, Dc = 1.333 g/cm3, μ= 0.095 mm-1, the final R =0.0550 and wR = 0.1483 for 2956 observed reflections with I 2γ(I). Compound 7(C13H19N3O2, Mr= 249.31) crystallizes in the monoclinic system, space group C2/c with a = 18.926(3), b =12.1853(17), c = 14.740(2) o,(I) = 125.6380(10)°, V = 2762.7(7) A3, Z = 8, F(000) = 1072, Dc=1.199 g/cm3, μ= 0.083 mm-1, the final R = 0.0554 and w R = 0.1468 for 2395 observed reflections with I 2σ(I). The preliminary bioassay results indicate that compound 6 exhibits notable fungicidal activities against Fusarium graminearum, Botrytis cinerea, Rhizoctonia cerealis and Colletotrichum capsici at the concentration of 100 μg/mL.     

中心对称型4,4’-双(N’-取代酰基硫脲基)取代联苯类衍生物的 合成及其晶体结构

以苯甲酸和2,4-二氯苯氧乙酸为原料合成取代酰基异硫氰酸酯, 再分别与4,4’-联苯二胺和3,3’-二甲基-4,4’-联苯二胺反应, 合成了3种中心对称型4,4’-双(N’-取代酰基硫脲基)取代联苯类衍生物. 产物结构经紫外光谱、红外光谱和核磁共振谱确认, 并用X射线单晶衍射分析法测定了化合物4,4’-双(N’-苯甲酰基硫脲基)联苯的晶体结构, 该晶体属于三斜晶系, P-1空间群, 晶胞参数: a＝0.53447(11) nm, b＝1.03086(13) nm, c＝1.15550(13) nm, α＝98.24(3)°, β＝96.95(3)°, γ＝99.43(3)°, Z＝2, Dc＝1.379 g/cm3, V＝0.61472(16) nm3, F(000)＝266, R1＝0.0506, wR2＝0.1335. 该分子呈中心对称分布, 存在两种分子内氢键N—H…O和C—H…S, 形成了毗邻的两个六元环结构, 同时通过分子间氢键N—H…S在分子间形成的R22(8)环把分子连接成无限延伸的一维链状结构, 再通过两种CH-π相互作用形成三维超分子结构.     

中心对称型4，4’-双（N′－取代酰基硫脲基）取代联苯类衍生物的合成及其晶体结构

以苯甲酸和2,4-二氯苯氧乙酸为原料合成取代酰基异硫氰酸酯,再分别与4,4＇-联苯二胺和3,3’-二甲基．4,4＇-联苯二胺反应,合成了3种中心对称型4,4’-双（N′-取代酰基硫脲基）取代联苯类衍生物．产物结构经紫外光谱、红外光谱和核磁共振谱确认,并用x射线单晶衍射分析法测定了化合物4,4＇-双（N′-苯甲酰基硫脲基）联苯的晶体结构,该晶体属于三斜晶系,P-1空间群,晶胞参数：a=0．53447（11）nm,b=1．03086（13）nm,c=1．15550（13）nm,α=98．24（3）°,β=96．95（3）°,γ=99．43（3）°,Z=2,Dc=1．379g／cm^3,V=0．61472（16）nm^3,F（000）=266,R1=0．0506,wR2=0．1335．该分子呈中心对称分布,存在两种分子内氢键N—H…O和C—H…s,形成了毗邻的两个六元环结构,同时通过分子间氢键N—H…S在分子间形成的R22（8）环把分子连接成无限延伸的一维链状结构,再通过两种CH-π相互作用形成三维超分子结构．     

丙环唑配合物的合成、缓释性能及生物活性研究

Five propiconazole(L) complexes (ML₂Cl₂, M=Zn(Ⅱ), Cu(Ⅱ), Co(Ⅱ); ML₄Cl₂, M=Ni(Ⅱ), Mn(Ⅱ)) were prepared and characterized by elemental analysis and IR. These complexes exhibited favorable controlled release property, it took 40 to 120 hours to release 85% amount of ligand in the water. The toxicity determination to Botrytis cinera, Rhizoctonia cerealis, Gibberella zeae, Fussrium moniliforme and Colletotrichum orbiculare indicated that the fungicidal activities of the complexes were better than that of the ligand except Mn-complex to Rhizoctonia cereali. The EC50 of Zn-propiconazole were 0.045 2～0.144 1 μg·mL^-1, Co- and Ni-propiconazole were 0.066 3～0.210 4 μg·mL^-1 and 0.183 9～0.340 7 μg·mL^-1, respectively, and Mn-propiconazole were only 0.353 6～0.538 0 μg·mL^-1. The growth regulation experiment to wheat seeding by dressing treating indicated that inhibiting activities of the complexes to root length and stem height were weaker than that of the ligand.     

3-(1′-烃氧亚氨基)乙基-4-羟基吡咯啉-2-酮类衍生物的合成与生物活性

以氨基酸乙酯为原料合成8种3-乙酰基-4-羟基吡咯啉-2-酮的类似物A, A与3种烃氧基胺盐酸盐反应合成了20个肟醚类衍生物3-(1'-烃氧亚氨基)乙基-4-羟基吡咯啉-2-酮(B), 其结构经 1H NMR, MS, IR和元素分析表征. 初步生物活性测定结果表明合成的化合物B具有一定的除草活性和抑制真菌活性.     

一维链状配位聚合物[Cu(CH3COO)(C5H5N)2]n的合成与晶体结构

The coordination polymer [Cu(CH3COO)(C5H5N)2]n was synthesized and its crystal structure has been determined by X-ray diffraction technique.The crystal belongs to monoclinic,space group C2/c with a=1.183 2(1) nm,b=1.512 1(2) nm,c=1.3911(1) nm,β=97.137(3)°,V=2.469 6(4) nm3,C12H13CuN2O2,Mr=280.78,Z=8,Dc=1.510 g·cm-3,μ=1.759 mm-1,F(000)=1 152,R1=0.048 2 and wR2=0.122 5 for 1 515 observed reflections [1>2σ(Ⅰ)].In the crystal the copper(Ⅲ) atom is tetra-coordinated primarily by two oxygen atoms of two symmetry-related carbexyl groups of acetate anions and two nitrogen atoms of two pyridine ligands in a parallelogram fashion.All of the pyridine rings linked to Cu(1) and Cu(2) are arranged centrosymmetrically on Cu(1).The neighboring copper complex molecules are linked together by the carboxylate oxygen atom of acetate anions to form an infinite one-dimensional linear chain structure.Moreover,π-π stacking interactions between intrachain pyridine molecules play the crucial role in constructing of the supramolecular structure.CCDC:709977.     

硒脲及其衍生物的合成和应用

硒脲及其衍生物具有抗真菌、抗肿瘤、抗癌等生物活性,可作为合成其它化合物的中间体和配体,还可用于增强显影剂的感光度。硒脲及取代硒脲的合成有取代脲法、氨腈法、异硒氰酸酯法等,缩氨基硒脲的合成有硒氰酸盐法和取代硫脲法,酰基硒脲的合成用常规法和相转移催化法。本文对硒脲及其衍生物的上述合成方法和应用作了介绍。     

力场/溶剂水模型对EGFRvⅢ抗原-MR1(scFv)抗体复合物的MM-PBSA计算精度的影响与实验验证

以表皮生长因子Ⅲ型突变体(EGFRvⅢ)抗原多肽与其抗体(MR1)及其人源化突变体的复合物结构为出发点,采用分子动力学中的6种常用力场及3种常用溶剂水模型,分别对上述抗原-抗体复合物进行100ns的分子动力学模拟与分子力学和连续介质模型计算自由能(MM-PBSA),并在实验上利用等温滴定量热(ITC)仪测定了抗原和抗体相互作用的热力学参数.通过在结构变化、能量变化及野生型与突变体比较等几个方面进行综合分析,给出了最佳的计算模型.对不同力场及水模型计算精度等相关问题进行了探讨.     

Synthesis and Crystal Structure of [Mn（DPMT）2Cl2（H2O）2]

The title compound [Mn(DPMT)2Cl2(H2O)2] (DPMT = 1-[[2-(2,4-dichlorophenyl)- 1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole) was synthesized by the reaction of MnCl2·4H2O and DPMT in ethanol solution and its structure was determined by single-crystal X-ray diffraction. The crystal belongs to monoclinic, space group P21/c with a = 23.913(4), b = 7.8883(13), c = 8.6291(14) , β = 95.816(3)o, V = 1619.4(5) 3, Z = 2, C24H26Cl6MnN6O6, Mr = 762.15, Dc = 1.563 g/cm3, μ = 0.950 mm-1, S = 1.045, F(000) = 774, R = 0.0462 and wR = 0.0981. The molecular structure is a centrosymmetric conformation, and two ligands are symmetrically located on both sides of the Mn atom. The manganese atom is surrounded by two nitrogen atoms from ligands, two chlorine atoms and two oxygen atoms from water molecules to form a slightly distorted octahedral geometry.